Monitoring of pesticide residue in bovine milk from Nadia district, West Bengal.

Monitoring of 210 bovine milk samples collected from local markets in the Nadia district of West Bengal during 2011 was performed. Samples were collected in summer and winter seasons. Analysis of pesticides was performed by using a multiresidue method validated in the laboratory. The quantification was performed using GC-ECD. Analysis revealed the presence of lindane in less than 1 % of milk samples. Endosulfan I and II were also detected and were found to exceed MRL recommended by Codex. Overall 1.90 % of the analyzed samples showed trace to measurable amount of pesticide residues. The monitored area provided pesticide residues data of milk, assisting in future scientific assessment on pesticide usage.

Macro-to-micro porous special bioactive glass and ceftriaxone-sulbactam composite drug delivery system for treatment of chronic osteomyelitis: an investigation through in vitro and in vivo animal trial.

A systematic and extensive approach incorporating in vitro and in vivo experimentation to treat chronic osteomyelitis in animal model were made using antibiotic loaded special bioactive glass porous scaffolds. After thorough characterization for porosity, distribution, surface charge, a novel drug composite were infiltrated by using vacuum infiltration and freeze-drying method which was subsequently analyzed by SEM-EDAX and studied for in vitro drug elution in PBS and SBF. Osteomyelitis in rabbit was induced by inoculation of Staphylococcus aureus and optimum drug-scaffold were checked for its efficacy over control and parenteral treated animals in terms of histopathology, radiology, in vivo drug concentration in bone and serum and implant-bone interface by SEM. It was optimized that 60P samples with 60-65% porosity (bimodal distribution of macro- to micropore) with average pore size ~60 µm and higher interconnectivity, moderately high antibiotic adsorption efficiency (~49%) was ideal. Results after 42 days showed antibiotic released higher than MIC against S. aureus compared to parenteral treatment (2 injections a day for 6 weeks). In vivo drug pharmacokinetics and SEM on bone-defect interface proved superiority of CFS loaded porous bioactive glass implants over parenteral group based on infection eradication and new bone formation.